0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pet Medicine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13P9468
Home | Market Reports | Pets & Animals
Global Pet Medicine Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pet Medicine Market Research Report 2025

Code: QYRE-Auto-13P9468
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pet Medicine Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Pet Medicine Market

Pet Medicine Market

The global market for Pet Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Well over half of the triplicate in the United States own a pet -- almost 80 million homes!Man "s best friend took a be the most iconic. But it" s been a dog, cat, horse, bird, fish, or lizard, pets need to be cared for, pet medical is required.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 33%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pet Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medicine.
The Pet Medicine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pet Medicine Market Report

Report Metric Details
Report Name Pet Medicine Market
Accounted market size in 2021 $ 38.3 billion
Base Year 2021
Segment by Type
  • External Use
  • Internal Use
Segment by Application
  • Dogs
  • Cats
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Dechra Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pet Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pet Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Pet Medicine Market share by region?

Ans: According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Medicine Market report?

Ans: The main players in the Pet Medicine Market are Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol, Bimeda Animal Health, Dechra Pharmaceuticals

What are the Application segmentation covered in the Pet Medicine Market report?

Ans: The Applications covered in the Pet Medicine Market report are Dogs, Cats, Other

What are the Type segmentation covered in the Pet Medicine Market report?

Ans: The Types covered in the Pet Medicine Market report are External Use, Internal Use

Recommended Reports

Veterinary Equipment

Pet Health

Veterinary Pharmaceuticals

1 Pet Medicine Market Overview
1.1 Product Definition
1.2 Pet Medicine by Type
1.2.1 Global Pet Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 External Use
1.2.3 Internal Use
1.3 Pet Medicine by Application
1.3.1 Global Pet Medicine Market Value by Application (2024 VS 2031)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pet Medicine Market Size Estimates and Forecasts
1.4.1 Global Pet Medicine Revenue 2020-2031
1.4.2 Global Pet Medicine Sales 2020-2031
1.4.3 Global Pet Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pet Medicine Market Competition by Manufacturers
2.1 Global Pet Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pet Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pet Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pet Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medicine, Product Type & Application
2.7 Global Key Manufacturers of Pet Medicine, Date of Enter into This Industry
2.8 Global Pet Medicine Market Competitive Situation and Trends
2.8.1 Global Pet Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pet Medicine Players Market Share by Revenue
2.8.3 Global Pet Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pet Medicine Market Scenario by Region
3.1 Global Pet Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pet Medicine Sales by Region: 2020-2031
3.2.1 Global Pet Medicine Sales by Region: 2020-2025
3.2.2 Global Pet Medicine Sales by Region: 2026-2031
3.3 Global Pet Medicine Revenue by Region: 2020-2031
3.3.1 Global Pet Medicine Revenue by Region: 2020-2025
3.3.2 Global Pet Medicine Revenue by Region: 2026-2031
3.4 North America Pet Medicine Market Facts & Figures by Country
3.4.1 North America Pet Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pet Medicine Sales by Country (2020-2031)
3.4.3 North America Pet Medicine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Medicine Market Facts & Figures by Country
3.5.1 Europe Pet Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pet Medicine Sales by Country (2020-2031)
3.5.3 Europe Pet Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Pet Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pet Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pet Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Medicine Market Facts & Figures by Country
3.7.1 Latin America Pet Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pet Medicine Sales by Country (2020-2031)
3.7.3 Latin America Pet Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pet Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pet Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Medicine Sales by Type (2020-2031)
4.1.1 Global Pet Medicine Sales by Type (2020-2025)
4.1.2 Global Pet Medicine Sales by Type (2026-2031)
4.1.3 Global Pet Medicine Sales Market Share by Type (2020-2031)
4.2 Global Pet Medicine Revenue by Type (2020-2031)
4.2.1 Global Pet Medicine Revenue by Type (2020-2025)
4.2.2 Global Pet Medicine Revenue by Type (2026-2031)
4.2.3 Global Pet Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Pet Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pet Medicine Sales by Application (2020-2031)
5.1.1 Global Pet Medicine Sales by Application (2020-2025)
5.1.2 Global Pet Medicine Sales by Application (2026-2031)
5.1.3 Global Pet Medicine Sales Market Share by Application (2020-2031)
5.2 Global Pet Medicine Revenue by Application (2020-2031)
5.2.1 Global Pet Medicine Revenue by Application (2020-2025)
5.2.2 Global Pet Medicine Revenue by Application (2026-2031)
5.2.3 Global Pet Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Pet Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Pet Medicine Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Pet Medicine Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Pet Medicine Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Company Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Elanco Pet Medicine Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Pet Medicine Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Company Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Virbac Pet Medicine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.7.1 Ceva Sante Animale Company Information
6.7.2 Ceva Sante Animale Description and Business Overview
6.7.3 Ceva Sante Animale Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ceva Sante Animale Pet Medicine Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Company Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vetoquinol Pet Medicine Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Bimeda Animal Health
6.9.1 Bimeda Animal Health Company Information
6.9.2 Bimeda Animal Health Description and Business Overview
6.9.3 Bimeda Animal Health Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bimeda Animal Health Pet Medicine Product Portfolio
6.9.5 Bimeda Animal Health Recent Developments/Updates
6.10 Dechra Pharmaceuticals
6.10.1 Dechra Pharmaceuticals Company Information
6.10.2 Dechra Pharmaceuticals Description and Business Overview
6.10.3 Dechra Pharmaceuticals Pet Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Dechra Pharmaceuticals Pet Medicine Product Portfolio
6.10.5 Dechra Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medicine Industry Chain Analysis
7.2 Pet Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medicine Production Mode & Process Analysis
7.4 Pet Medicine Sales and Marketing
7.4.1 Pet Medicine Sales Channels
7.4.2 Pet Medicine Distributors
7.5 Pet Medicine Customer Analysis
8 Pet Medicine Market Dynamics
8.1 Pet Medicine Industry Trends
8.2 Pet Medicine Market Drivers
8.3 Pet Medicine Market Challenges
8.4 Pet Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Pet Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pet Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pet Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pet Medicine Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Pet Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pet Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pet Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pet Medicine Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pet Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pet Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pet Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Pet Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pet Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pet Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pet Medicine Sales by Region (2020-2025) & (MT)
 Table 18. Global Pet Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Pet Medicine Sales by Region (2026-2031) & (MT)
 Table 20. Global Pet Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Pet Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pet Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Pet Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pet Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Pet Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pet Medicine Sales by Country (2020-2025) & (MT)
 Table 27. North America Pet Medicine Sales by Country (2026-2031) & (MT)
 Table 28. North America Pet Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pet Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pet Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pet Medicine Sales by Country (2020-2025) & (MT)
 Table 32. Europe Pet Medicine Sales by Country (2026-2031) & (MT)
 Table 33. Europe Pet Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pet Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pet Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pet Medicine Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Pet Medicine Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Pet Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pet Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pet Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pet Medicine Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Pet Medicine Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Pet Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pet Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pet Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pet Medicine Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Pet Medicine Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Pet Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pet Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pet Medicine Sales (MT) by Type (2020-2025)
 Table 51. Global Pet Medicine Sales (MT) by Type (2026-2031)
 Table 52. Global Pet Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Pet Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Pet Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pet Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pet Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Pet Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Pet Medicine Price (USD/MT) by Type (2020-2025)
 Table 59. Global Pet Medicine Price (USD/MT) by Type (2026-2031)
 Table 60. Global Pet Medicine Sales (MT) by Application (2020-2025)
 Table 61. Global Pet Medicine Sales (MT) by Application (2026-2031)
 Table 62. Global Pet Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Pet Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Pet Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pet Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pet Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Pet Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Pet Medicine Price (USD/MT) by Application (2020-2025)
 Table 69. Global Pet Medicine Price (USD/MT) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Pet Medicine Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Zoetis Pet Medicine Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Merck Pet Medicine Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Elanco Company Information
 Table 86. Elanco Description and Business Overview
 Table 87. Elanco Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Elanco Pet Medicine Product
 Table 89. Elanco Recent Developments/Updates
 Table 90. Bayer Company Information
 Table 91. Bayer Description and Business Overview
 Table 92. Bayer Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. Bayer Pet Medicine Product
 Table 94. Bayer Recent Developments/Updates
 Table 95. Virbac Company Information
 Table 96. Virbac Description and Business Overview
 Table 97. Virbac Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Virbac Pet Medicine Product
 Table 99. Virbac Recent Developments/Updates
 Table 100. Ceva Sante Animale Company Information
 Table 101. Ceva Sante Animale Description and Business Overview
 Table 102. Ceva Sante Animale Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Ceva Sante Animale Pet Medicine Product
 Table 104. Ceva Sante Animale Recent Developments/Updates
 Table 105. Vetoquinol Company Information
 Table 106. Vetoquinol Description and Business Overview
 Table 107. Vetoquinol Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Vetoquinol Pet Medicine Product
 Table 109. Vetoquinol Recent Developments/Updates
 Table 110. Bimeda Animal Health Company Information
 Table 111. Bimeda Animal Health Description and Business Overview
 Table 112. Bimeda Animal Health Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Bimeda Animal Health Pet Medicine Product
 Table 114. Bimeda Animal Health Recent Developments/Updates
 Table 115. Dechra Pharmaceuticals Company Information
 Table 116. Dechra Pharmaceuticals Description and Business Overview
 Table 117. Dechra Pharmaceuticals Pet Medicine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Dechra Pharmaceuticals Pet Medicine Product
 Table 119. Dechra Pharmaceuticals Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pet Medicine Distributors List
 Table 123. Pet Medicine Customers List
 Table 124. Pet Medicine Market Trends
 Table 125. Pet Medicine Market Drivers
 Table 126. Pet Medicine Market Challenges
 Table 127. Pet Medicine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pet Medicine
 Figure 2. Global Pet Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pet Medicine Market Share by Type: 2024 & 2031
 Figure 4. External Use Product Picture
 Figure 5. Internal Use Product Picture
 Figure 6. Global Pet Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pet Medicine Market Share by Application: 2024 & 2031
 Figure 8. Dogs
 Figure 9. Cats
 Figure 10. Other
 Figure 11. Global Pet Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pet Medicine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Pet Medicine Sales (2020-2031) & (MT)
 Figure 14. Global Pet Medicine Average Price (USD/MT) & (2020-2031)
 Figure 15. Pet Medicine Report Years Considered
 Figure 16. Pet Medicine Sales Share by Manufacturers in 2024
 Figure 17. Global Pet Medicine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Pet Medicine Players: Market Share by Revenue in Pet Medicine in 2024
 Figure 19. Pet Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Pet Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Pet Medicine Sales Market Share by Country (2020-2031)
 Figure 22. North America Pet Medicine Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Pet Medicine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Pet Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Pet Medicine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Pet Medicine Revenue Market Share by Region (2020-2031)
 Figure 34. China Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Pet Medicine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Pet Medicine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Pet Medicine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Pet Medicine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Pet Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Pet Medicine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Pet Medicine by Type (2020-2031)
 Figure 56. Global Pet Medicine Price (USD/MT) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Pet Medicine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Pet Medicine by Application (2020-2031)
 Figure 59. Global Pet Medicine Price (USD/MT) by Application (2020-2031)
 Figure 60. Pet Medicine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String